Founder and Partner
H VenturesCheck size: H Ventures does not publish a firm or person-specific check-size range on its current website.
Jongwoo focuses on biohealthcare businesses whose scientific value can be protected through strong global IP strategy. His diligence lens spans drug platforms, cell and gene therapies, medical AI, licensing and defensible patent portfolios.
H Ventures states that it seeks category-leading teams with durable technical advantages, defensible intellectual property, disciplined execution and the resilience to build through a long company journey.
No personal pass list is public. The firm explicitly avoids chasing short-term trends and appears less aligned with weak technical diligence, shallow IP moats or teams unable to execute toward category leadership.
Present the technical breakthrough, independent validation, IP position, commercialization milestones, team execution record and a credible path from the current stage to category leadership and exit.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Jongwoo Ryu is Founder and Partner of H Ventures and Managing Partner of Sunjung Patent & Law Firm. A registered patent attorney with more than 15 years in biotechnology patent prosecution and global IP strategy, he holds an MS in Biochemistry and BS in Microbiology from Seoul National University and has advised biotech companies from formation through licensing and public listings.